USANA (USNA) director acquires 1,057 shares via RSU conversion
USANA Health Sciences (USNA) reported an insider stock acquisition by a director.
Rhea-AI Filing Summary
USANA Health Sciences (USNA) reported an insider stock acquisition by a director. On 10/23/2025, the director acquired 1,057 shares of common stock through the settlement of restricted stock units, coded M (derivative conversion).
The shares were delivered at a stated price of $0. Following the transaction, the director beneficially owns 7,986 shares directly, with 2,115 RSUs remaining outstanding. Each RSU represents the right to receive one share of USNA common stock. The RSUs vest in four 25% installments on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 1,057 | $0.00 | $0.00 |
| Exercise | Common Stock | 1,057 | $0.00 | $0.00 |
Footnotes (2)
- F1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
- F2. Restricted Stock Units vest 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did USNA's director report on Form 4 for 10/23/2025?
What derivative securities remain after the transaction for USNA?
What is the vesting schedule for the reported USNA RSUs?
What does transaction code M indicate in the USNA filing?
What was the price for the RSU conversion in the USNA Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.